{
    "doi": "https://doi.org/10.1182/blood.V114.22.5093.5093",
    "article_title": "Molecular Characterization in Two Families Bearing Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD) IN Rosario, Argentina. ",
    "article_date": "November 20, 2009",
    "session_type": "Red Cell Erythropoiesis Structure and Function, Metabolism, and Survival (Excluding Iron)",
    "abstract_text": "Abstract 5093 Introduction: G6PD deficiency is a frequent worldwide enzymopathy, with sex-linked inheritance, the gene that codifies the enzyme localizes at the X chromosome. Males are hemizygous (Hem) for disease, while women are heterozygous (Het), i.e. carriers, and very rarely homozygous, or double heterozygous and consequently, develop disease. There are over 120 deficient molecular variants observed in Afro-Americans and in the malaria endemic region of the Mediterranean Basin. In previous studies in Argentina we have reported a low prevalence, 0,2-0,3 %, although the predominant molecular variants are unknown. Most of deficiencies are clinically detected when the patient is submitted to oxidative stress produced by infections, therapeutic drugs, or Vicia fava ingestion, develops an acute hemolytic anemia (AHA) of variable severity. Materials and Methods: Two male patients and their families were studied. 1) A 1 : 45y aged male, with AHA after bean ingestion, as well as the following relatives: mother (M 1 ); sister (S 1 ); three nephews (N 1, N 2, N 3) and a niece (N 4 ) without positive AHA history. 2) A 2 : 55y aged male, with two AHA episodes in childhood and adolescence, one of them associated with an infection, and the mother (M 2 ). The evaluation clinical and hematological of the patients were normal Laboratory assays: Hemogram, Hemoglobin (Hb) (Coulter AcT10); Reticulocytes (Ret); Brewer test (B.T.); Heinz bodies (HB); Cytochemical method modified (Gurbuz, N; et al): NV: 86,8 % positive cells (CYT); Enzymatic activity (EA) Kinetic Method (Beutler-OMS): NV: 8.0\u00b11.6 G6PD/gHb IU and Polymerase Chain Reaction with Enzyme Restriction (PCR-ER) for characterization of different variants: G6PD Med(563G\u25a1T) , G6PD A 376(A\u25a1G) , G6PD A 376(A\u25a1G) 202(G\u25a1A) ; G6PD A 376(A\u25a1G) 680 (G\u25a1T) y G6PD A 376(A\u25a1G) 968 (T\u25a1C) . Results:  F . Hb g/l . Ret % . BT . HB. % . CYT % . EA - G6PD gHb IU % . PCR-ER variant . A 1  155 3.0 (+) 68 12 0.3 3.7 Hem A \u2013202  M 1  130 2.7 (\u00b1) 34 20 5.7 69.1 Het A \u2013202  S 1  150 2.1 (\u00b1) 46 15 4.1 50.6 Het A \u2013202  N 1  144 1.4 (+) 48 12 0.3 3.7 Hem A -202  N 2  160 0.9 (-) 23 89 8.4 104.0 Normal N 3  139 2.1 (+) 52 8 0.2 2.5 Hem A - 202  N 4  145 1.0 (\u00b1) 55 9 4.5 56.2 Het A -202  A 2  150 1.6 (+) 66 21 0.6 7.4 Hem G6PD Med  M 2  132 1.8 (\u00b1) 79 10 3.9 15.0 Het G6PD Med  F . Hb g/l . Ret % . BT . HB. % . CYT % . EA - G6PD gHb IU % . PCR-ER variant . A 1  155 3.0 (+) 68 12 0.3 3.7 Hem A \u2013202  M 1  130 2.7 (\u00b1) 34 20 5.7 69.1 Het A \u2013202  S 1  150 2.1 (\u00b1) 46 15 4.1 50.6 Het A \u2013202  N 1  144 1.4 (+) 48 12 0.3 3.7 Hem A -202  N 2  160 0.9 (-) 23 89 8.4 104.0 Normal N 3  139 2.1 (+) 52 8 0.2 2.5 Hem A - 202  N 4  145 1.0 (\u00b1) 55 9 4.5 56.2 Het A -202  A 2  150 1.6 (+) 66 21 0.6 7.4 Hem G6PD Med  M 2  132 1.8 (\u00b1) 79 10 3.9 15.0 Het G6PD Med  View Large Conclusions: The EA confirmed the deficit of probands and nephews N 1 and N 3 without previous AHA history. The heterozygous character of females was not defined by this method but PCR-ER and CYT mod. supported the obliged carriers heterozygosis and the potential ones, demonstrating that CYT is more sensitive for carrier detection than other screening techniques or EA. The deficient phenotype was correlated with the detected variants, since the Mediterranean G6PD: G6PD Med (563G\u25a1T) (Type II, OMS) and G6PD A 376(A\u25a1G) 202(G\u25a1A) (Type III, OMS) are associated with AHA induced by infections or Vicia Fava ingestion. The finding in Argentina of these two variants, that are frequent in the Mediterranean region, it is in accordance with the fact that our population has mainly Italian, Spanish (family 1) and Jewish (family 2) ancestors. The detection of deficient without hemolysis, as well as carriers is of the utmost importance in genetic counseling. Disclosures: No relevant conflicts of interest to declare.",
    "topics": [
        "argentina",
        "glucose-6-phosphate dehydrogenase deficiency",
        "glucosephosphate dehydrogenase",
        "polymerase chain reaction",
        "infections",
        "enzymes",
        "gamma hydroxybutyrate",
        "hemoglobin",
        "hemolytic anemia, acute",
        "malaria"
    ],
    "author_names": [
        "Irma del Luja\u0301n, ILA Acosta, Biochemical., Associate, Professor, PhD, in, Biochemistry. Specialist, in, Hematology",
        "Susana Mabel SMP Pe\u0301rez, Biochemical., Associate, Professor, PhD, in, Biochemistry. Specialist, in, Hematology",
        "Sabrina SB Botta, Jr, Biotechnologist",
        "Virginia VR Rescia, MD, Specialist, in, Hematology",
        "Mauro MD Davoli, Clinical, Medical",
        "Angela Cristina ACM Milani, Sr, Biochemical., Associate, Professor, PhD, in, Biochemistry. Specialist, in, Hematology"
    ],
    "author_dict_list": [
        {
            "author_name": "Irma del Luja\u0301n, ILA Acosta, Biochemical., Associate, Professor, PhD, in, Biochemistry. Specialist, in, Hematology",
            "author_affiliations": [
                "Bioqui\u0301mica Cli\u0301nica. Ca\u0301tedra de Hematologi\u0301a, Facultad de Ciencias Bioqui\u0301micas y Farmace\u0301uticas. Universidad Nacional de Rosario. Suipacha 531., Rosario, Argentina, "
            ],
            "author_rank": 1,
            "first_author": 1,
            "last_author": 0
        },
        {
            "author_name": "Susana Mabel SMP Pe\u0301rez, Biochemical., Associate, Professor, PhD, in, Biochemistry. Specialist, in, Hematology",
            "author_affiliations": [
                "Bioqui\u0301mica Cli\u0301nica. Ca\u0301tedra de Hematologi\u0301a, Facultad de Ciencias Bioquimicas y Farmace\u0301uticas. Universidad Nacional de Rosario. Suipacha 531., Rosario, Argentina, "
            ],
            "author_rank": 2,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Sabrina SB Botta, Jr, Biotechnologist",
            "author_affiliations": [
                "Bioqui\u0301mica Cli\u0301nica. Ca\u0301tedra de Hematologi\u0301a, Facultad de Ciencias Bioquimicas y Farmace\u0301uticas. Universidad Nacional de Rosario. Suipacha 531, Rosario, Argentina, "
            ],
            "author_rank": 3,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Virginia VR Rescia, MD, Specialist, in, Hematology",
            "author_affiliations": [
                "Fundacio\u0301n de la Hemofilia., Fundacio\u0301n de la Hemofilia Filial Rosario. Hospital Provincial del Centenario. Suipacha 531., Rosario, Argentina, "
            ],
            "author_rank": 4,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Mauro MD Davoli, Clinical, Medical",
            "author_affiliations": [
                "Fundacio\u0301n de la Hemofilia, Fundacio\u0301n de la Hemofilia Filial Rosario. Hospital Provincial del Centenario. Suipacha 531, Rosario, Argentina, "
            ],
            "author_rank": 5,
            "first_author": 0,
            "last_author": 0
        },
        {
            "author_name": "Angela Cristina ACM Milani, Sr, Biochemical., Associate, Professor, PhD, in, Biochemistry. Specialist, in, Hematology",
            "author_affiliations": [
                "Bioqui\u0301mica Cli\u0301nica. Ca\u0301tedra de Hematologi\u0301a, Facultad de Ciencias Bioqui\u0301micas y Farmace\u0301uticas. Universidad Nacional de Rosario. Suipacha 531, Rosario, Argentina"
            ],
            "author_rank": 6,
            "first_author": 0,
            "last_author": 1
        }
    ],
    "datetime_abstract_obtained": "2022-05-13T06:47:58",
    "is_scraped": "1"
}